MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α
Xu, Haitao, Zhao, Liang, Fang, Qiuju, Sun, Jianmin, Zhang, Songyan, Zhan, Chao, Liu, Shujie, Zhang, Yubao
Published in PloS one (22.12.2014)
Published in PloS one (22.12.2014)
Get full text
Journal Article